(Q40462682)

20 September 2017

title

GATA1, cytidine deaminase, and the high cure rate of Down syndrome children with acute megakaryocytic leukemia. (English)

1 reference

20 September 2017

1 reference

Yubin Ge

1

1 reference

20 September 2017

Mark L Stout

2

1 reference

20 September 2017

Dana A Tatman

3

1 reference

20 September 2017

Tanya L Jensen

4

1 reference

20 September 2017

Steven Buck

5

1 reference

20 September 2017

Ronald L Thomas

6

1 reference

20 September 2017

Yaddanapudi Ravindranath

7

1 reference

20 September 2017

Larry H Matherly

8

1 reference

20 September 2017

Jeffrey W Taub

9

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

Journal of the National Cancer Institute

20 September 2017

published in

1 reference

20 September 2017

volume

97

1 reference

20 September 2017

issue

3

1 reference

20 September 2017

page(s)

226-231

1 reference

An effective chemotherapeutic regimen for acute myeloid leukemia and myelodysplastic syndrome in children with Down's syndrome.

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI026

Myelodysplasia and acute megakaryoblastic leukemia in Down's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI026

Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI026

GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI026

Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI026

Acquired mutations in GATA1 in neonates with Down's syndrome with transient myeloid disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI026

Frequent mutations in the GATA-1 gene in the transient myeloproliferative disorder of Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI026

Nucleoside analogues: mechanisms of drug resistance and reversal strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI026

The role of cytidine deaminase and GATA1 mutations in the increased cytosine arabinoside sensitivity of Down syndrome myeloblasts and leukemia cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI026

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJI026

1 reference

20 September 2017

1 reference